Back

Select your region

Arrange a consultation about stem cells

Learn more

List of life saving
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
1 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic Disorder 2026 Experimental Therapy Poland 14
2 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 4
3 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4
4 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
5 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 5,3
6 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
7 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,11
8 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 67,2
9 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 50,7
10 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 4,6
11 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
12 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,7
13 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
14 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 2,9
15 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,1
16 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 60,7
17 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 5,5
18 Cord Tissue Allogeneic Autism Neurology 2026 Experimental Therapy United Arab Emirates 6
19 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 4,1
20 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 4,9
21 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 8,7
22 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 3,2
23 Cord Tissue Autologous Cerebral Palsy Neurology 2026 Experimental Therapy Slovakia 2
24 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 6
25 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 13
26 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 8
27 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 9
28 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
29 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
30 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
31 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 3
32 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,1
33 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2026 Experimental Therapy Poland 76,3
34 Cord Tissue Allogeneic – Unrelated Encephalitis, Myelitis Neurology 2026 Experimental Therapy Poland 36,6
35 Cord Tissue Allogeneic – Unrelated Stress Incontinence Urology 2026 Experimental Therapy Poland 62,4
36 Cord Tissue Allogeneic – Unrelated aGvHD, PNH Hematology 2026 Experimental Therapy Poland 17,8
37 Cord Tissue Allogeneic – Unrelated Progressive Bulbar Palsy Neurology 2026 Experimental Therapy Poland 58,1
38 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 6,2
39 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2026 Experimental Therapy Poland 59,4
40 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 15,5
41 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 12,1
42 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 10
43 Cord Tissue Allogeneic – Unrelated MSA, Multiple System Atrophy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 53,1
44 Cord Tissue Allogeneic – Unrelated Stress Incontinence Gynecology 2026 Experimental Therapy Szpital Uniwersytecki w Krakowie ul. Mikołaja Kopernika 79,11
45 Cord Tissue Allogeneic – Unrelated Progressive Bulbar Palsy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 65,1
46 Cord Tissue Allogeneic – Unrelated MSA, Multiple System Atrophy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 61,3
47 Cord Tissue Allogeneic Related Spondylosis + Lumbar Disc Disease Rheumatology 2026 Experimental Therapy Slovakia , Malacky 32
48 Cord Tissue Autologus Autism Neurology 2026 Experimental Therapy Slovakia , Malacky 3
49 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,6
50 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
51 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,2
52 Cord Blood Allogeneic – Unrelated Acute Leukemia in remission, Pancytopenia after treatment Hematology 2026 Standard Therapy Denmark 18, 6
53 Cord Blood Allogeneic – Related Juvenile Myelomonocytic Leukemia (JMML) Hematology 2026 Standard Therapy Germany 10, 10
54 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,9
55 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 7,2
56 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,5
57 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,1
58 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,6
59 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 7,6
60 Cord Blood Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 7,8
61 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
62 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4,5
63 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 3,5
64 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
65 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
66 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
67 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,5
68 Cord Blood Allogeneic – Related Diamond-Blackfan Anemia (DBA) Hematology 2026 Standard Therapy Germany 10, 1
69 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Poland, Lublin, Uniwersytecki Szpital Kliniczny 7,11
70 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Poland, Lublin, Uniwersytecki Szpital Kliniczny 7,4
71 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Slovakia , Malacky 3
72 Bone Marrow Family Allogeneic T-Cell Lymphoma Hematology 2026 Standard Therapy Netherlands 65
73 Bone Marrow Family Allogeneic Other Malignancy Hematology 2026 Standard Therapy France 51
74 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 27
75 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 14
76 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
77 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 43
78 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 68
79 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 69
80 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 67
81 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 64
82 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 73
83 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 26
84 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 74
85 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 66
86 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Romania 25
87 Bone Marrow Family Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2026 Standard Therapy USA 65
88 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 62
89 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 63
90 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 47
91 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Czechia 67
92 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Sweden 74
93 Bone Marrow Family Allogeneic Non-Hodgkin Lymphoma Hematology 2026 Standard Therapy Germany 72
94 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Ukraine 40
95 Bone Marrow Family Allogeneic No Data Hematology 2026 Standard Therapy Germany 70
96 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2026 Standard Therapy Hungary 35
97 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 71
98 Bone Marrow Family Allogeneic Primary Myelofibrosis Hematology 2026 Standard Therapy Poland 37
99 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
100 Bone Marrow Family Allogeneic Fanconi Anemia Hematology 2026 Standard Therapy Germany 4